Isavy Biotech
Next-Gen cryopreservation technology for the life sciences industry
Isavy markets biomimetic antifreeze proteins to optimise biological preservation, thereby improving cell viability and industrial productivity without requiring new equipment.
The challenge they want to solve
Isavy addresses the toxicity and slowness of current preservation methods (freezing, freeze drying) that destroy up to 80% of fragile cells and create energy-intensive bottlenecks in industrial production.
The impact they have
Isavy’s technology doubles production capacity and reduces energy consumption by two-thirds, while guaranteeing immediately functional cells after thawing. These innovations are particularly useful in advancing the production of new drugs.
The way we measure it
We measure the carbon footprint reduction of labs and industrials using Isavy’s solution, and the reduction in toxic products use such as DMSO; Isavy also measures the improvement in post-thawing cell viability rate.
